logo

Sutro Biopharma Inc (STRO)



Trade STRO now with
  Date
  Headline
5/21/2020 7:20:02 AM Sutro Biopharma Names Craig Berman VP Of Clinical Development; Promotes Regina Cheng To VP Of Finance And Controller
5/21/2020 7:12:18 AM Sutro Biopharma Names Carlos Paya Chair Of Scientific Advisory Board And Lainie Martin Member Of Clinical Advisory Board
5/12/2020 12:00:34 AM Sutro Biopharma Announces Pricing Of 11 Mln Shares At $7.75/Shr
5/11/2020 4:04:15 PM Sutro Biopharma Announces Proposed Public Offering
4/27/2020 12:03:43 AM Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data For Dose Escalation Study Of STRO-002
3/16/2020 7:21:33 AM Sutro Biopharma FY Net Loss Widens To $55.7 Mln From $35.3 Mln Last Year
3/12/2020 7:07:10 AM Sutro Biopharma Extends First Cytokine Derivative Research Program Under Collaboration With Merck By One Year
1/8/2020 9:27:57 AM Sutro Biopharma Adds James Panek To Board
4/2/2019 7:11:26 AM Wedbush Is Cutting SUTRO BIOPHARMA INC (STRO) Q4 19 Rev. Estimate To 11.3 M From 23.8 M
4/2/2019 7:11:13 AM Wedbush Is Cutting SUTRO BIOPHARMA INC (STRO) Q3 19 Rev. Estimate To 11.3 M From 13.8 M
4/2/2019 7:11:00 AM Wedbush Is Increasing SUTRO BIOPHARMA INC (STRO) Q2 19 Rev. Estimate To 11.3 M From 3.8 M
4/2/2019 7:10:51 AM Wedbush Is Increasing SUTRO BIOPHARMA INC (STRO) Q1 19 Rev. Estimate To 11.3 M From 3.8 M
4/2/2019 7:10:27 AM Wedbush Is Cutting SUTRO BIOPHARMA INC (STRO) FY19 Estimate To -2.34 From -1.89
4/2/2019 7:10:15 AM Wedbush Is Cutting SUTRO BIOPHARMA INC (STRO) Q4 19 Estimate To -0.62 From -0.01
4/2/2019 7:09:57 AM Wedbush Is Lowering SUTRO BIOPHARMA INC (STRO) Q3 19 Estimate To -0.56 From -0.33
4/2/2019 7:09:43 AM Wedbush Is Increasing SUTRO BIOPHARMA INC (STRO) Q2 19 Estimate To -0.61 From -0.80
4/2/2019 7:09:30 AM Wedbush Is Raising SUTRO BIOPHARMA INC (STRO) Q1 19 Estimate To -0.55 From -0.76